HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 10 of 10
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleHosoda, Shunichi; Suda, Goki; Sho, Takuya; Ogawa, Koji; Kimura, Megumi; Yang, Zijian; Yoshida, Sonoe; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Miyagishima, Takuto; Sakamoto, NaoyaLow baseline CXCL9 predicts early progressive disease in unresectable HCC with atezolizumab plus bevacizumab treatment-Liver Cancer-Jun-2023
articleNakatsumi, Hiroshi; Komatsu, Yoshito; Muranaka, Tetsuhito; Yuki, Satoshi; Kawamoto, Yasuyuki; Harada, Kazuaki; Dazai, Masayoshi; Tateyama, Miki; Sasaki, Yusuke; Miyagishima, Takuto; Tsuji, Yasushi; Katagiri, Masaki; Nakamura, Michio; Sogabe, Susumu; Hatanaka, Kazuteru; Meguro, Takashi; Kobayashi, Tomoe; Ishiguro, Atsushi; Muto, Osamu; Shindo, Yoshiaki; Kotaka, Masahito; Ando, Takayuki; Takagi, Ryo; Sakamoto, Naoya; Sakata, YuStudy protocol for HGCSG1801 : A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies-Frontiers in oncology-9-Nov-2022
articleSho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, NaoyaEfficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150-Cancers-15-Aug-2022
articleNakano, Shintaro; Kawamoto, Yasuyuki; Yuki, Satoshi; Harada, Kazuaki; Miyagishima, Takuto; Sogabe, Susumu; Dazai, Masayoshi; Sato, Atsushi; Ishiguro, Atsushi; Nakamura, Michio; Kajiura, Shinya; Takahashi, Yasuo; Tateyama, Miki; Hatanaka, Kazuteru; Tsuji, Yasushi; Sasaki, Takahide; Shindo, Yoshiaki; Kobayashi, Tomoe; Yokota, Isao; Sakamoto, Naoya; Sakata, Yuh; Komatsu, YoshitoStudy protocol of the HGCSG1803 : a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer-BMJ Open-May-2022
articleSenjo, Hajime; Onozawa, Masahiro; Hidaka, Daisuke; Yokoyama, Shota; Yamamoto, Satoshi; Tsutsumi, Yutaka; Haseyama, Yoshihito; Nagashima, Takahiro; Mori, Akio; Ota, Shuichi; Sakai, Hajime; Ishihara, Toshimichi; Miyagishima, Takuto; Kakinoki, Yasutaka; Kurosawa, Mitsutoshi; Kobayashi, Hajime; Iwasaki, Hiroshi; Hashimoto, Daigo; Kondo, Takeshi; Teshima, TakanoriHigh CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia-Scientific reports-2022
articleSho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, NaoyaEarly response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting-JGH open-Feb-2020
article (author version)Hidaka, Daisuke; Onozawa, Masahiro; Hashiguchi, Junichi; Miyashita, Naohiro; Kasahara, Kohei; Fujisawa, Shinichi; Hayase, Eiko; Okada, Kohei; Shiratori, Souichi; Goto, Hideki; Sugita, Junichi; Nakagawa, Masao; Hashimoto, Daigo; Kahata, Kaoru; Endo, Tomoyuki; Yamamoto, Satoshi; Tsutsumi, Yutaka; Haseyama, Yoshihito; Nagashima, Takahiro; Mori, Akio; Ota, Shuichi; Sakai, Hajime; Ishihara, Toshimichi; Imai, Kiyotoshi; Miyagishima, Takuto; Kakinoki, Yasutaka; Kurosawa, Mitsutoshi; Kobayashi, Hajime; Iwasaki, Hiroshi; Shimizu, Chikara; Kondo, Takeshi; Teshima, TakanoriWilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia : A Hokkaido Leukemia Net Study-Clinical Lymphoma, Myeloma and Leukemia-Nov-2018
articleKawamoto, Yasuyuki; Komatsu, Yoshito; Yuki, Satoshi; Sawada, Kentaro; Muranaka, Tetsuhito; Harada, Kazuaki; Nakatsumi, Hiroshi; Fukushima, Hiraku; Ishiguro, Atsushi; Dazai, Masayoshi; Hatanaka, Kazuteru; Nakamura, Michio; Iwanaga, Ichiro; Uebayashi, Minoru; Sogabe, Susumu; Kobayashi, Yoshimitsu; Miyagishima, Takuto; Ono, Kota; Sakamoto, Naoya; Sakata, YuhStudy protocol of HGCSG1404 SNOW study : a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer-BMC cancer-8-Dec-2017
articleKomatsu, Yoshito; Okita, Kenji; Yuki, Satoshi; Furuhata, Tomohisa; Fukushima, Hiraku; Masuko, Hiroyuki; Kawamoto, Yasuyuki; Isobe, Hiroshi; Miyagishima, Takuto; Sasaki, Kazuaki; Nakamura, Michio; Ohsaki, Yoshinobu; Nakajima, Junta; Tateyama, Miki; Eto, Kazunori; Minami, Shinya; Yokoyama, Ryoji; Iwanaga, Ichiro; Shibuya, Hitoshi; Kudo, Mineo; Oba, Koji; Takahashi, YasuoOpen-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron-Cancer science-Jul-2015
article (author version)Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, Hiroshi; Kobayashi, Yoshimitsu; Iwanaga, Ichiro; Nakamura, Michio; Hatanaka, Kazuteru; Miyagishima, Takuto; Kudo, Mineo; Munakata, Masaki; Meguro, Takashi; Tateyama, Miki; Sakata, YuhPhase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer-Acta Oncologica-Sep-2012
Showing results 1 to 10 of 10

 

Hokkaido University